Performance analysis of Moleculin Biotech (MBRX)
Annual Return
Over the past 3 years, MBRX has had an average annual return of -80.16%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, MBRX has had an average annual return of -73.66%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, MBRX has had an average annual return of -60.63%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Jun 2, 2016, MBRX has had an average annual return of -60.17%, underperforming the benchmark SPY, which returned +15.54% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.00% | -91.67% | -86.59% | -19.00% | -43.04% | -61.04% | -12.94% | -12.00% | -44.09% | -18.42% | -71.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | -50.00% | +0% | +0% | +100% | -50.00% | -50.00% | ||||||
| 2025 | -12.50% | -14.29% | -22.22% | +7.14% | -20.00% | -66.67% | +125% | -44.44% | +40% | -14.29% | -33.33% | -50.00% | -91.67% |
| 2024 | -41.34% | +24.76% | -37.40% | -14.63% | -5.71% | -25.76% | -10.20% | -20.45% | +11.43% | -7.69% | +5.56% | -36.84% | -86.59% |
| 2023 | +18.55% | -3.82% | -20.63% | -22.00% | -15.38% | -8.33% | +9.09% | -11.36% | -23.93% | +11.24% | +26.26% | +43.20% | -19.00% |
| 2022 | -18.81% | -7.94% | +27.93% | -10.78% | -5.44% | -3.51% | +16.56% | -12.50% | -28.25% | -5.88% | +44.23% | -26.33% | -43.04% |
| 2021 | +4.02% | -14.96% | -3.52% | -14.00% | +5.47% | -0.78% | -15.03% | -1.23% | -2.65% | -12.00% | -21.64% | -9.98% | -61.04% |
| 2020 | -4.90% | -22.89% | -9.06% | +78.64% | +0% | -11.23% | +18.84% | -23.78% | -7.30% | -14.96% | +12.85% | +2.15% | -12.94% |
| 2019 | +28.85% | -0.72% | -39.09% | +66.63% | -11.14% | +4.20% | -12.80% | +3.60% | -1.70% | -3.60% | -5.61% | -9.42% | -12.00% |
| 2018 | +1.08% | +5.87% | -9.57% | +1.11% | -1.10% | -0.53% | -5.05% | +1.18% | -6.98% | -35.00% | +26% | -20.63% | -44.09% |
| 2017 | -21.93% | -35.96% | +2.67% | -22.21% | -16.61% | +146.36% | +59.88% | -15.73% | -5.14% | -19.24% | -17.61% | +16.95% | -18.42% |
Drawdown analysis of Moleculin Biotech (MBRX)
The maximum drawdown for the MBRX was -99.99%, occurring on Feb 19, 2026. This drawdown has not yet recovered.
The current MBRX drawdown is -99.99%.
Since Jun 2, 2016 MBRX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jun 3, 2016 | 2441 | Feb 19, 2026 | Ongoing | Ongoing | Ongoing |